SYMPLICITY HTN-3 Trial: No Blood Pressure Reduction in Patients with Resistant Hypertension Treated with Renal Denervation
MurielCunningham
Harvard Medical School and Brigham and Women's Hospital, Boston, Massachusetts, USA (At time of ACC.06 publication, Cleveland Clinic Cardiovascular Coordinating Center, Cleveland, Ohio, USA)
Harvard Medical School and Brigham and Women's Hospital, Boston, Massachusetts, USA (At time of ACC.06 publication, Cleveland Clinic Cardiovascular Coordinating Center, Cleveland, Ohio, USA)
ABPM=ambulatory blood pressure monitor; BP=blood pressure; HTN=hypertension; M=months; SBP=systolic blood pressure.Reproduced from Kandzari DE et al. Catheter-based renal denervation for resistant hypertension: rationale and design of the SYMPLICITY HTN-3 Trial. Clin Cardiol 2012; 35(9):528–535. With permission from John Wiley and Sons.